These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29867492)

  • 21. Selenium Supplementation Protects Against Arsenic-Trioxide-Induced Cardiotoxicity Via Reducing Oxidative Stress and Inflammation Through Increasing NAD
    Yang HB; Yuan W; Li WD; Mao S
    Biol Trace Elem Res; 2023 Aug; 201(8):3941-3950. PubMed ID: 36376713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
    Zheng CY; Lam SK; Li YY; Ho JC
    Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyphenol-rich apple (Malus domestica L.) peel extract attenuates arsenic trioxide induced cardiotoxicity in H9c2 cells via its antioxidant activity.
    Vineetha VP; Girija S; Soumya RS; Raghu KG
    Food Funct; 2014 Mar; 5(3):502-11. PubMed ID: 24441683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Overview on Arsenic Trioxide-Induced Cardiotoxicity.
    Vineetha VP; Raghu KG
    Cardiovasc Toxicol; 2019 Apr; 19(2):105-119. PubMed ID: 30617460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and
    Kuo YJ; Liu YJ; Way TD; Chiang SY; Lin JG; Chung JG
    Exp Ther Med; 2017 Jun; 13(6):3388-3396. PubMed ID: 28587418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbic Acid Sensitizes Colorectal Carcinoma to the Cytotoxicity of Arsenic Trioxide
    Tian W; Wang Z; Tang NN; Li JT; Liu Y; Chu WF; Yang BF
    Front Pharmacol; 2020; 11():123. PubMed ID: 32153415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes.
    Raghu KG; Cherian OL
    J Trace Elem Med Biol; 2009; 23(1):61-8. PubMed ID: 19203718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.
    Li T; Ma R; Zhang Y; Mo H; Yang X; Hu S; Wang L; Novakovic VA; Chen H; Kou J; Bi Y; Yu B; Fang S; Wang J; Zhou J; Shi J
    Cell Death Dis; 2018 Jan; 9(2):75. PubMed ID: 29362482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies.
    Chou WC; Dang CV
    Curr Opin Hematol; 2005 Jan; 12(1):1-6. PubMed ID: 15604884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of protocatechuic acid against doxorubicin- and arsenic trioxide-induced toxicity in cardiomyocytes.
    Shafiee F; Safaeian L; Gorbani F
    Res Pharm Sci; 2023 Apr; 18(2):149-158. PubMed ID: 36873272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug.
    Raghu KG; Yadav GK; Singh R; Prathapan A; Sharma S; Bhadauria S
    J Environ Pathol Toxicol Oncol; 2009; 28(3):241-52. PubMed ID: 19888912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
    BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway.
    Guo J; Guo Q; Fang H; Lei L; Zhang T; Zhao J; Peng S
    Eur J Pharmacol; 2014 Aug; 737():117-24. PubMed ID: 24858368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
    Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
    Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
    Wang Z; Zhang H; Dai L; Song T; Li P; Liu Y; Wang L
    Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide: mechanisms of action.
    Davison K; Mann KK; Miller WH
    Semin Hematol; 2002 Apr; 39(2 Suppl 1):3-7. PubMed ID: 12012315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
    Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
    Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
    Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.